Apr 13
|
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
|
Apr 12
|
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
|
Apr 12
|
Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
Apr 12
|
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
|
Apr 11
|
Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable
|
Apr 11
|
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
|
Apr 10
|
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
|
Apr 8
|
Ten doctors on FDA panel reviewing Abbott heart device had financial ties with company
|
Apr 8
|
Abbott (ABT) Faces Low Testing Demand, Currency Headwinds
|
Apr 8
|
The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services
|
Apr 5
|
Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks
|
Apr 5
|
Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
|
Apr 5
|
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
|
Apr 2
|
Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval
|
Apr 2
|
Abbott's heart valve repair device gains US FDA approval
|
Apr 2
|
UPDATE 3-Abbott's heart valve repair device gains US FDA approval
|
Apr 2
|
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
|
Apr 1
|
Abbott (ABT) Declines More Than Market: Some Information for Investors
|
Apr 1
|
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
|
Mar 29
|
3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List
|